Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments (Narrative) (Details)

v3.8.0.1
Derivative Financial Instruments (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Maximum net exposure to counterparty $ 697  
Sales 53,267 $ 41,556
Reclassification Out Of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Cash Flow Hedges [Member]    
Sales $ (325) $ 296